chevron_leftBack
As of 16 June 2026, Zhejiang Hisun Pharmaceutical Co., Ltd. has a market cap of $1.94B USD, ranking #7200 globally and #1775 in China.
It ranks #579 in the Healthcare sector, and #228 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.94BUSD
13.15B CNY
Enterprise Value
$2.22BUSD
15.04B CNY
Revenue (TTM)
$1.52BUSD
10.31B CNY
EBITDA (TTM)
$331.27MUSD
2.24B CNY
Net Income (TTM)
$103.7MUSD
702.17M CNY
EBITDA Margin
22%
Profit Margin
6.8%
PE Ratio
19.0
Forward PE
24.9
PS Ratio
1.3
PB Ratio
1.5
EV/EBITDA
6.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Weihong Xiao
open_in_new
Employees
7,994
Founded
1956
Website
hisunpharm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.3% | 0.9% | 12% | 5.9% | 2.9% | 29% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
600267
浙江海正药业股份有限公司 Class A
ISIN: CNE0000013Z2
Shares Out.:
Shares Outstanding:
1.158B1
Shares Float:
1.158B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
11.32 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.89B
3K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.67B
2K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
1K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
868%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.52B
751%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
725%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
39K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
28K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
18K%
|
97.4
|
|
SIX: RO
|
$320.51B
16K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.14B
15K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
14K%
|
15.1
|
chevron_leftBack